rs886037712
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_177438.3(DICER1):c.4309_4312del(p.Asp1437MetfsTer16) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,459,564 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. D1437D) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_177438.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DICER1 | NM_177438.3 | c.4309_4312del | p.Asp1437MetfsTer16 | frameshift_variant | 23/27 | ENST00000343455.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DICER1 | ENST00000343455.8 | c.4309_4312del | p.Asp1437MetfsTer16 | frameshift_variant | 23/27 | 1 | NM_177438.3 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1459564Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 725914
GnomAD4 genome ? Cov.: 32
ClinVar
Submissions by phenotype
DICER1-related tumor predisposition Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Oct 05, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 254332). This premature translational stop signal has been observed in individuals with cystic nephroma and pleuropulmonary blastoma, pituitary blastoma, and embryonal rhabdomyosarcoma (PMID: 21036787, 22180160, 24839956, 26925222). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asp1437Metfs*16) in the DICER1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DICER1 are known to be pathogenic (PMID: 19556464, 21266384). - |
Pathogenic, criteria provided, single submitter | curation | Foulkes Cancer Genetics LDI, Lady Davis Institute for Medical Research | Jul 01, 2019 | ACMG criteria met: PVS1, PM2, PP1, PP4 - |
Pathogenic, criteria provided, single submitter | clinical testing | International Pleuropulmonary Blastoma Registry, Children's Hospitals and Clinics of Minnesota | Nov 10, 2014 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 29, 2018 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 19, 2021 | The c.4309_4312delGACT pathogenic mutation, located in coding exon 22 of the DICER1 gene, results from a deletion of 4 nucleotides at nucleotide positions 4309 to 4312, causing a translational frameshift with a predicted alternate stop codon (p.D1437Mfs*16). This maternally inherited mutation was detected in siblings diagnosed with cystic nephroma; one brother affected bilaterally also was found to have subtle lung cysts (Bahubeshi A et al. J Med Genet, 2010 Dec;47:863-6; Khan NE et al. Pediatr Nephrol, 2018 Dec;33:2281-2288). This mutation was also reported in a patient with pleuropulmonary blastoma at age 4 and embryonal rhabdomyosarcoma of the cervix and bladder at ages 8 and 12, respectively (Doros L et al. Pediatr Blood Cancer, 2012 Sep;59:558-60). This mutation was identified in an infant with pituitary blastoma and seen in conjunction with a somatic DICER1 mutation (de Kock L et al. Acta Neuropathol, 2014 Jul;128:111-22). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at